Expression of c-erbB2 oncogene product in different tumours and its standardised evaluation

Analytical Cellular Pathology

Volumn 10, Issue 2, 1996, Pages 149-160

  Tannapfel, Andrea ^a   Kühn, Reinhard ^a   Keßler, Hermann ^a   Wittekind, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Bladder carcinoma; c erbB2; Colorectal carcinoma; Evaluation; Gastric carcinoma; Immunohistochemistry; Standardisation criteria; Western blot

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL; STOMACH CARCINOMA; BIOSYNTHESIS; BLADDER TUMOR; COLORECTAL TUMOR; COMPARATIVE STUDY; GENE EXPRESSION; METHODOLOGY; PATHOLOGY; PROTO ONCOGENE; STOMACH TUMOR; TRANSITIONAL CELL CARCINOMA; WESTERN BLOTTING;

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; COLORECTAL NEOPLASMS; GENE EXPRESSION; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, ERBB-2; STOMACH NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0029670499     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumours. Cancer Res 1993;53:5251.
2. 2 expression in normal, pre-malignant and malignant tissue of the corpus and cervix uteri. Virchows Arch A Pathol Anat J 1990;417:477.
3. Chang K, Ding I, Kern FG, Willingham MC. Immunohistochemical analysis of p53 and HER/neu proteins in human tumours. J Histochem Cytochem 1991;39:1281.
4. 2 protein in transitional cell carcinoma of the urinary bladder. J Pathol 1993;169:35.
5. De Potter CR, van Daele S, Van de Vijver MJ, Pauwels C, Maertens G, deBoever J, Vanderkerckhove D, Roels H. The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues. Histopathology 1989;15:351.
6. 2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol 1989;159:107.
7. 2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations. J Clin Pathol 1994;47:23.
8. 2 in human breast carcinomas. Mol Cell Probes 1988;2:383.
9. Hanna W, Kahn HJ, Andrulis I. Distribution and patterns of staining of neu oncogene product in benign and malignant breast diseases. Mod Pathol 1990;3:455.
10. Hermanek P, Wittekind Ch. Residual Tumor (R) classification and prognosis. Semin Surg Oncol 1994;10:12.
11. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577.
12. 2 immunostaining: problems with interpretation. J Clin Pathol 1994;47:816.
13. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L, Robinson RA. p185neu expression in human lung adenocarcinoma predicts shortened survival. Cancer Res 1990;50:5184.
14. 2 oncogene product to known prognostic indicators of colorectal cancer. Surg Oncol 1992;1:97.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680.
16. 2 amplification and overexpression in human tumours. Cancer Treat Res 1992;61:161.
17. McGuire WL. Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst 1991;83:154.
18. 2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 1993;72:2083.
19. 2 protein overexpression are associated with early invasion and metastasis in bladder cancer. Virchows Arch A Pathol Anat J 1993;423:329.
20. 2 gene product in urinary bladder cancer. J Urol 1991;145:423.
21. 2 gene product in transitional cell carcinoma of the urinary tract. Ultrastruct Pathol 1990; 14:399.
22. 8 in human breast cancer: impact of fixation. J Pathol 1994;173:65.
23. Sadasivan R, Morgan R, Jennings S, Austenfeld M, Van-Veldhuizen P, Stephens R, Noblem. Overexpression of Her/neu may be an indicator of poor prognosis in prostate cancer. J Urol 1993;150:126.
24. 2 and p53 in human stomach cancer cells. Hum Pathol 1993;24:584.
25. Schlechter AL, Stern DF, Vaidyauathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA. The neu oncogene: an erbB-related gene encoding a 185 000 Mw tumour antigen. Nature 1984;312:513.
26. 2 gene product-like expression in urothelial carcinomas of the human bladder. Its value as a prognostic indicator in superficial tumours. Pathologica 1991;83:413.
27. 2 activation in paraffin-embedded tissue by immunohistochemistry. Hum Pathol 1992;23:1141.
28. Slamon DJ, Godolphin W, Jones LA. Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707.
29. Taylor CR. An exaltation of experts: concerted efforts in the standardization of immunohistochemistry. Appl Immunohistochem 1993;1:232.
30. Taylor CR. Quality assurance and standardization in immunohistochemistry. A proposal for the Annual Meeting of the Biological Stain Commission, June 1991. Biotech Histochem 1992;67:110.
31. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350.
32. UICC. TNM Classification of Malignant Tumors, 4th ed. 2nd revision. Berlin: Springer, 1992.
33. 2 oncoprotein in human breast carcinomas: immunohistochemical assessment correlates with gene amplification. Lancet 1987;2:69.
34. Walker RA, Varley JM. The molecular biology of human breast cancer. In: Lemoine NR, Wright NA, eds. The Molecular Pathology of Cancer. New York: Cold Spring Harbor Laboratory Press, 1993;31.
35. 2 protein and epidermal growth factor receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status. Cancer 1993;72:2628.
36. Wittekind D. Standardization of dyes and stains for automated cell pattern recognition. Anal Quant Cytol Histol 1985;7:6.
37. Wood DJ, Wartinger DD, Reuter V, Cordon-Cardo C, Fair WR, Chaganti RS. DNA, RNA and immunhistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder. J Urol 1991;146:1398.
38. 2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 1991;63:967.
39. 2/neu proto-oncogene in human bladder cancer. Mol Carcinogen 1990;3:254.